• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment failure of ofloxacin in Campylobacter pylori infection.

作者信息

Glupczynski Y, Labbe M, Burette A, Delmee M, Avesani V, Bruck C

出版信息

Lancet. 1987 May 9;1(8541):1096. doi: 10.1016/s0140-6736(87)90527-7.

DOI:10.1016/s0140-6736(87)90527-7
PMID:2883434
Abstract
摘要

相似文献

1
Treatment failure of ofloxacin in Campylobacter pylori infection.
Lancet. 1987 May 9;1(8541):1096. doi: 10.1016/s0140-6736(87)90527-7.
2
[Ofloxacin in the therapy of Campylobacter pylori-positive duodenal ulcer. A prospective controlled randomized study].
Dtsch Med Wochenschr. 1987 Sep 11;112(37):1407-11. doi: 10.1055/s-2008-1068260.
3
[Ofloxacin in therapy of "resistant" duodenal ulcer. A pilot study].
Z Gastroenterol. 1988 Mar;26(3):155-9.
4
Methodological problems of randomized clinical trials in the treatment of duodenal ulcer, "gastritis" and Campylobacter pylori infection.十二指肠溃疡、“胃炎”及幽门螺杆菌感染治疗中随机临床试验的方法学问题
Gastroenterol Clin Biol. 1989;13(1 Pt 1):112B-115B.
5
[Comparison of clinical efficacy of ofloxacin COFLX: DL-8280) and pipemidic acid (PPA) in acute infectious diarrhea by a double-blind method. The Japan Research Committee of Ofloxacin, Research Group for Acute Infectious Diarrhea].
Kansenshogaku Zasshi. 1984 Oct;58(10):965-81. doi: 10.11150/kansenshogakuzasshi1970.58.965.
6
Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities.呋喃妥因治疗幽门螺杆菌相关性胃炎。卡耶塔诺·埃雷迪亚大学和约翰·霍普金斯大学胃肠生理学工作组。
Gastroenterology. 1988 Nov;95(5):1178-84. doi: 10.1016/0016-5085(88)90348-4.
7
[Therapy of Campylobacter pylori infection].[幽门螺杆菌感染的治疗]
Leber Magen Darm. 1988 Feb;18(1):38-45.
8
Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection.幽门螺杆菌感染治疗的细菌学和药理学基础。
Gastroenterol Clin Biol. 1989;13(1 Pt 1):96B-100B.
9
[What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
Internist (Berl). 1988 Nov;29(11):745-54.
10
Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.幽门螺杆菌相关性胃炎：阿莫西林双盲安慰剂对照试验
Am J Gastroenterol. 1988 Apr;83(4):365-72.

引用本文的文献

1
diagnosis and therapy in the era of antimicrobial stewardship.抗菌药物管理时代的诊断与治疗
Therap Adv Gastroenterol. 2021 Dec 21;14:17562848211064080. doi: 10.1177/17562848211064080. eCollection 2021.
2
In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori.HPi1（一种针对幽门螺杆菌的选择性抗菌剂）的体外和体内活性
Antimicrob Agents Chemother. 2014 Jun;58(6):3255-60. doi: 10.1128/AAC.02573-13. Epub 2014 Mar 31.
3
The use of ciprofloxacin for the elimination of mycoplasma from naturally infected cell lines.
用环丙沙星消除自然感染细胞系中的支原体。
Cytotechnology. 1988 Nov;1(4):355-8. doi: 10.1007/BF00365081.
4
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.TAK-083（一种用于治疗幽门螺杆菌感染的药物）的体外和体内抗菌活性
Antimicrob Agents Chemother. 2001 Sep;45(9):2455-9. doi: 10.1128/AAC.45.9.2455-2459.2001.
5
Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft model.阿莫西林在人幽门螺杆菌感染异种移植模型中的胃穿透性。
Antimicrob Agents Chemother. 1999 Aug;43(8):1909-13. doi: 10.1128/AAC.43.8.1909.
6
In vitro activities of new quinolones against Helicobacter pylori.新型喹诺酮类药物对幽门螺杆菌的体外活性
Antimicrob Agents Chemother. 1997 Dec;41(12):2790-2. doi: 10.1128/AAC.41.12.2790.
7
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.用于根除幽门螺杆菌感染的药物的风险效益评估。
Drug Saf. 1996 Jul;15(1):30-52. doi: 10.2165/00002018-199615010-00003.
8
Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.胃质子泵抑制剂兰索拉唑对幽门螺杆菌脲酶活性具有强效抑制作用：对幽门螺杆菌细胞具有独特的选择性作用。
Antimicrob Agents Chemother. 1993 Apr;37(4):769-74. doi: 10.1128/AAC.37.4.769.
9
Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.兰索拉唑单独及与抗菌药物联合对幽门螺杆菌的抗菌特性。
Eur J Clin Microbiol Infect Dis. 1995 May;14(5):391-9. doi: 10.1007/BF02114894.
10
Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents.幽门螺杆菌临床分离株对24种抗菌和抗溃疡药物的敏感性。
Eur J Epidemiol. 1988 Jun;4(2):154-7. doi: 10.1007/BF00144743.